A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus

The emerging variants of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID‐19) vaccines which could be effective for both wild‐type SARS‐CoV‐2 and mutant strains. In the current study, we formulated...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Cai, Yang, Jingyun, He, Xuemei, Hong, Weiqi, Lei, Hong, Chen, Zimin, Shen, Guobo, Yang, Li, Li, Jiong, Wang, Zhenling, Song, Xiangrong, Wang, Wei, Lu, Guangwen, Wei, Xiawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242662/
https://www.ncbi.nlm.nih.gov/pubmed/34226895
http://dx.doi.org/10.1002/mco2.72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242662/
https://www.ncbi.nlm.nih.gov/pubmed/34226895
http://dx.doi.org/10.1002/mco2.72

Ejemplares similares